Mednax (MD) Misses Q1 EPS by 2c; Guides Q2 EPS Below Views
Tweet
Share
E-mailGet Alerts MD Hot Sheet
Join SI Premium – FREE
Mednax (NYSE: MD) reported Q1 EPS of $0.98, $0.02 worse than the analyst estimate of $1.00. Revenue for the quarter came in at $422.6 million versus the consensus estimate of $423.46 million.
Mednax sees Q2 2012 EPS of $1.15-$1.21, versus the consensus of $1.28.
For earnings history and earnings-related data on Mednax (MD) click here.
Mednax sees Q2 2012 EPS of $1.15-$1.21, versus the consensus of $1.28.
For earnings history and earnings-related data on Mednax (MD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
